Utilizing PET Imaging To Visualize Immune Activation and Tumor Apoptosis
Molecular Pharmaceutics · 07.04.2025 · 22 (4) · 2122-2130
DOI: 10.1021/acs.molpharmaceut.4c01314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.03.2025. Verfasst von Yuan Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, …. Hauptthemen laut MEDLINE: Apoptosis, Positron-Emission Tomography, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Provincial Key Laboratory of Molecular Imaging.
Abstract (Originalsprache)
Immunotherapy-induced tumor apoptosis is one of the crucial pathways in tumor cell death. This study aimed to explore the potential of PET imaging for noninvasively visualizing pivotal processes in immunotherapy, specifically immune activation and tumor apoptosis, by targeting granzyme-B and caspase-3. Bioinformatic analyses validated granzyme-B and caspase-3 expression in cancer tissues and their associations with immune infiltration and patient prognosis using the GEPIA and TIMER databases. Two radiolabeled probes, [68Ga]Ga-GZP and [68Ga]Ga-AC3, were used to specifically target granzyme-B and caspase-3 for PET imaging, respectively. CT26 xenograft tumor models were assigned to PD-1 inhibitor or PBS control groups to receive treatment every 3 days, with imaging conducted at baseline and after each treatment. Imaging results showed significantly increased tumor uptake of both [68Ga]Ga-GZP and [68Ga]Ga-AC3 in the ICB-treated group compared to controls, indicating early molecular changes in immune activation and tumor apoptosis. Immunofluorescence analysis further supported these findings, revealing upregulated granzyme-B and caspase-3 expression in treated tumor tissues. Immunohistochemistry also confirmed increased T-cell infiltration and elevated levels of effector molecules, such as IFN-γ and TNF-α, in the ICB group. This study demonstrates that granzyme-B and caspase-3 PET/CT can noninvasively visualize early molecular changes in immunotherapy-induced CD8+ T cell activation and tumor apoptosis. These noninvasive diagnostic techniques hold significant promise for future clinical applications, particularly for a more accurate evaluation of immunotherapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.
- Hubei Key Laboratory of Molecular Imaging, Wuhan 430022, Hubei Province, China.
- Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan 430022, Hubei Province, China.
ORCID-Profile: Xiao Zhang
Förderung
- National Natural Science Foundation of China
- Hubei Provincial Key Laboratory of Molecular Imaging
Zitieren
APA
Feng, Y., Lin, Z., Hu, W., Wang, X., Zhang, Z., Lan, X., & Zhang, X. (2025). Utilizing PET Imaging To Visualize Immune Activation and Tumor Apoptosis. Molecular Pharmaceutics, 22(4), 2122-2130. https://doi.org/10.1021/acs.molpharmaceut.4c01314
Vancouver
Feng Y, Lin Z, Hu W, Wang X, Zhang Z, Lan X, et al. Utilizing PET Imaging To Visualize Immune Activation and Tumor Apoptosis. Molecular Pharmaceutics. 2025;22(4):2122-2130. doi:10.1021/acs.molpharmaceut.4c01314
BibTeX
@article{Feng2025,
author = {Feng, Yuan and Lin, Zhaoguo and Hu, Wenzhu and Wang, Xingyi and Zhang, Zihan and Lan, Xiaoli and Zhang, Xiao},
title = {Utilizing PET Imaging To Visualize Immune Activation and Tumor Apoptosis},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {4},
pages = {2122--2130},
doi = {10.1021/acs.molpharmaceut.4c01314}
}
EUVIMED